Meta Platform Inc April X Right Prices:
As Expected on my previous chart now lets tidy up the numbers while Retest is happening!
We first calculate the X - Right Price for March and week 1, April 2024 as Retest will finish before week 3 arrive and the reason we do this is simply April support was confirmed over the March.
Lets breakdown!
The retest must hold within the key level of $504.84 , $501.92, possibly will need to go to $494.39, $489.67 as April made March a support but left without making a correct retest.
We now calculate prices for whole March only, which will be as follow:
New support = $535.56 Follow by $538.50
$541.37
$546.07 Follow by $547.96
Execution Price = $550.24 , $553.63, $552.20, $554.86
Distribution price = $562.95
As Expected on my previous chart now lets tidy up the numbers while Retest is happening!
We first calculate the X - Right Price for March and week 1, April 2024 as Retest will finish before week 3 arrive and the reason we do this is simply April support was confirmed over the March.
Lets breakdown!
The retest must hold within the key level of $504.84 , $501.92, possibly will need to go to $494.39, $489.67 as April made March a support but left without making a correct retest.
We now calculate prices for whole March only, which will be as follow:
New support = $535.56 Follow by $538.50
$541.37
$546.07 Follow by $547.96
Execution Price = $550.24 , $553.63, $552.20, $554.86
Distribution price = $562.95
Institutional Note:
For institutional review, independent verification, or strategic collaboration:
institutions@bmoses.com.au
For institutional review, independent verification, or strategic collaboration:
institutions@bmoses.com.au
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Institutional Note:
For institutional review, independent verification, or strategic collaboration:
institutions@bmoses.com.au
For institutional review, independent verification, or strategic collaboration:
institutions@bmoses.com.au
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.